Saijuan Zhang Selected Research

islatravir

12/2021	A phase 1, open-label study to evaluate the drug interaction between islatravir (MK-8591) and the oral contraceptive levonorgestrel/ethinyl estradiol in healthy adult females.
12/2021	Lack of a Clinically Meaningful Drug Interaction Between the HIV-1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil Fumarate.
11/2021	Safety and Pharmacokinetics of Once-Daily Multiple-Dose Administration of Islatravir in Adults Without HIV.
7/2021	A Phase 1 Study to Evaluate the Drug Interaction Between Islatravir (MK-8591) and Doravirine in Adults Without HIV.
1/2020	Safety, pharmacokinetics, and antiretroviral activity of islatravir (ISL, MK-8591), a novel nucleoside reverse transcriptase translocation inhibitor, following single-dose administration to treatment-naive adults infected with HIV-1: an open-label, phase 1b, consecutive-panel trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Saijuan Zhang Research Topics

Disease

6	Infections 01/2022 - 01/2020
2	HIV Infections (HIV Infection) 12/2021 - 07/2021

Drug/Important Bio-Agent (IBA)

6	NucleosidesIBA 01/2022 - 01/2020
5	islatravirIBA 12/2021 - 01/2020
3	Reverse Transcriptase InhibitorsIBA 01/2022 - 07/2021
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2021 - 01/2020
2	ulonivirineIBA 01/2022 - 01/2022
1	Antiviral Agents (Antivirals)IBA 01/2022
1	doravirineIBA 07/2021
1	RNA (Ribonucleic Acid)IBA 01/2020